This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Gerald L. Klein, MD
Advertisement
Articles by Gerald L. Klein, MD
Advertisement
Latest Updated Articles
- Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
4
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
5
